|
|
Article: What's in the pipeline for dry eye and ocular allergy?
- Article from:
- Ophthalmology Times
- Article date:
- September 15, 2007
- Author:
CopyrightCopyright Advanstar Communications, Inc. Sep 15, 2007. Provided by ProQuest LLC. (Hide copyright information)
|
Pharmaceutical development
New therapeutics focus on causes, prevention
Dry eye and ocular allergy are bothersome to patients and present challenges to clinicians who, until recently, had limited treatment options that were typically directed at alleviating symptoms. Now, however, new therapeutic agents in the pipeline could change all of that. Researchers have begun developing therapies for dry eye that are directed at treating lhe underlying causes rather than symptoms. In addition, new therapies tor ocular allergy are focused on preventing the allergic reaction. This article discusses the newest agents being developed for dry eye and ocular allergy and reviews existing treatments ...